Concepedia

Alexandra Pitchford

AP

Statistics

Publications

4

Citations

167

H-Index

4

Active since

2021

Affiliations

Leicester Royal Infirmary(Current)

University of Leeds

University College London

Worcestershire Acute Hospitals NHS Trust

Cancer Research UK Clinical Trials Unit

Alexandra Pitchford is an author at Leicester Royal Infirmary specializing in medicine, cancer immunotherapy, and immunotherapy.

Publications per year

2021–2023

4

Publications

4

Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial

Peter Hillmen, Alexandra Pitchford, Adrian Bloor et al. · The Lancet Oncology · 2023 · 106 citations · Full text

, , +14

Ibrutinib Plus Rituximab Is Superior to FCR in Previously Untreated CLL: Results of the Phase III NCRI FLAIR Trial

Peter Hillmen, Alexandra Pitchford, Adrian Bloor et al. · Blood · 2021 · 36 citations

, , +5

Sudden or Cardiac Deaths on Ibrutinib-Based Therapy Were Associated with a Prior History of Hypertension or Cardiac Disease and the Use of ACE-Inhibitors at Study Entry: Analysis from the Phase III NCRI FLAIR Trial

Talha Munir, Alexandra Pitchford, Adrian Bloor et al. · Blood · 2021 · 15 citations

, , +9

Combination of Ibrutinib Plus Venetoclax with MRD-Driven Duration of Treatment Results in a Higher Rate of MRD Negativity in IGHV Unmutated Than Mutated CLL: Updated Interim Analysis of FLAIR Study

Talha Munir, Alexandra Pitchford, Adrian Bloor et al. · Blood · 2022 · 10 citations

, , +17

1–4 of 4